Today: 30 June 2026
Uber stock slips ahead of earnings as France driver dispute adds a new wrinkle
4 February 2026
1 min read

Uber stock slips ahead of earnings as France driver dispute adds a new wrinkle

New York, Feb 3, 2026, 20:37 EST — The market has closed.

  • Uber shares dropped 3.6% Tuesday, underperforming the broader, softer U.S. market.
  • Quarterly results from the company are scheduled before the market opens on Wednesday.
  • A new regulatory battle in France is drawing attention again as the report approaches.

Shares of Uber Technologies, Inc. dropped 3.6% Tuesday, closing at $77.93 and lagging behind a broadly weak session for U.S. stocks. The Nasdaq tumbled 1.43%, the Dow slipped 0.34%, and DoorDash declined 2.73%. Uber’s trading volume surged well above its 50-day average, according to MarketWatch data.

Uber will release its fourth-quarter and full-year 2025 earnings before the market opens on Wednesday. The company has arranged a conference call for 8 a.m. Eastern, according to its announcement.

Timing is crucial. The report offers a near-term reality check on ride-hailing and delivery demand—and, just as critical, on whether Uber can grow profits while still investing enough in drivers and discounts to hold onto market share.

Another issue looms: the ongoing battle over gig-worker classification in Europe. Investors have watched that fight escalate into fees, back payments, and stricter regulations—often fast.

Wall Street expects earnings near 79 cents per share on about $14.3 billion in revenue, based on current estimates and market previews. The spotlight often falls on “gross bookings,” which measures the total dollar value of rides and orders, as well as adjusted EBITDA, a profit figure that excludes certain items. Kiplinger

Uber announced Monday it’s in talks with Urssaf, following a media report claiming the agency ruled that Uber should have classified drivers as employees. Investigative outlet Revue21 said Urssaf is demanding 1.2 billion euros in social security contributions plus 512 million euros in penalties, covering 71,194 drivers from 2019 to 2022. Uber described the talks as “collaborative, transparent, and open.” Reuters

Investors tuning into Wednesday’s call will focus on updates to bookings and profit forecasts, watching closely for signals that incentives might be climbing again. Costs linked to regulation and litigation may also shift sharply from one quarter to the next.

The wider scene remains unsettled. A Reuters markets column pointed to Tuesday’s selloff as sparked by fresh worries that new AI tools might squeeze margins in software and services. Added geopolitical tensions only sharpened the cautious mood.

Uber’s shares have dropped roughly 24% from their 52-week peak, tightening the margin for any negative outlook revisions. This shifts the focus squarely onto the guidance’s quality, not just whether the company beats or misses estimates.

The setup works both ways. Strong demand and solid margins might lure buyers back, but a cautious outlook, signs of weaker rides, or another costly twist in the European worker-status debate could weigh on the shares.

The next catalyst arrives with the report ahead of Wednesday’s opening bell, then management’s call at 8 a.m. ET. Traders will focus on bookings, profits, and any news from the France negotiations.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) tops Australian growth stocks with large insider holdings
    June 30, 2026, 3:11 AM EDT. Telix Pharmaceuticals (ASX:TLX) is at the front of Australian growth stocks with high insider ownership, seen as a sign of management confidence. The biopharma group, focused on radiopharmaceuticals in cancer imaging and care, pulled in about US$803.8 million in sales, most of that coming from the U.S. The company's market cap stands at A$5.5 billion. Telix's cancer pipeline is broad, and its commercial footing is firm. Its key products, Illuccix and Gozellix, support 2026 revenue targets of US$950-970 million. There's still risk from regulatory and pricing pressure, but insiders remain aligned, and partnerships with United Imaging and Regeneron support the growth story. Also mentioned: Lindian Resources (ASX:LIN), market cap A$1.7 billion, which is pushing ahead on a rare earths project in Malawi. Both names show that shareholder interest tracks with insider backing.
Xero share price jumps on AI push and fresh US payments numbers — here’s what investors watch next
Previous Story

Xero share price jumps on AI push and fresh US payments numbers — here’s what investors watch next

Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held
Next Story

Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held

Go toTop